Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M154Revenue $M0.5Net Margin (%)0Z-Score19.1
Enterprise Value $M133EPS $-0.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book7.110-y EBITDA Growth Rate %-3.5Quick Ratio9.1Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-15.9Current Ratio9.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-47.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-56.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M67.2ROI % (ttm)-93.3Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CPRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Miller SteveCOO 2014-06-04Buy100,000$2.174.61 view
MCENANY PATRICK JPresident and CEO 2014-05-21Buy25,000$1.8920.11 view
O'Keeffe Charles BDirector 2014-05-19Buy10,000$1.8324.04 view
O'Keeffe Charles BDirector 2014-04-16Buy5,000$2.0212.38 view
MCENANY PATRICK JPresident and CEO 2014-02-07Buy25,000$1.8224.73 view
O'Keeffe Charles BDirector 2014-02-05Buy10,000$1.8125.41 view
Tierney David SDirector 2013-10-23Buy8,000$2.0311.82 view
O'Keeffe Charles BDirector 2013-10-21Buy10,000$1.8423.37 view
MCENANY PATRICK JPresident and CEO 2013-10-21Buy50,000$1.5942.77 view
MCENANY PATRICK JPresident and CEO 2013-02-19Buy50,000$0.46393.48 view

Press Releases about CPRX :

    Quarterly/Annual Reports about CPRX:

    News about CPRX:

    Articles On GuruFocus.com
    Largest Insider Buys of the Week Oct 25 2013 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) May 17 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 25,000 Shares Nov 16 2009 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 12 2009 
    Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results Aug 07 2009 

    More From Other Websites
    Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results Aug 14 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Aug 14 2014
    Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results Aug 14 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report Aug 13 2014
    Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients... Aug 11 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Aug 11 2014
    Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients... Aug 11 2014
    Biotech Stock Mailbag: Arrowhead, Catalyst Pharma Aug 01 2014
    Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference Jun 19 2014
    Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index Jun 18 2014
    Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference May 29 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Financials May 23 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal... May 19 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... May 16 2014
    Catalyst Pharmaceutical reports Q1 EPS (4c), consensus (6c) May 16 2014
    The Shuman Law Firm Investigates Catalyst Pharmaceutical Partners, Inc. May 15 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report May 15 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Apr 23 2014
    Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S.... Apr 23 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive... Apr 17 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide